0 false false false false false false true false false false true false No description of principal activity 2022-07-01 Sage Accounts Production Advanced 2021 - FRS102_2021_Charity xbrli:pure xbrli:shares iso4217:GBP 05668473 2022-07-01 2023-06-30 05668473 2023-06-30 05668473 2022-06-30 05668473 2021-07-01 2022-06-30 05668473 2022-06-30 05668473 2021-06-30 05668473 bus:LeadAgentIfApplicable 2022-07-01 2023-06-30 05668473 char:Trustee1 2022-07-01 2023-06-30 05668473 char:Trustee2 2022-07-01 2023-06-30 05668473 bus:CompanySecretary1 2022-07-01 2023-06-30 05668473 char:TotalUnrestrictedFunds 2022-06-30 05668473 char:TotalEndowmentFunds 2022-06-30 05668473 char:TotalUnrestrictedFunds 2023-06-30 05668473 char:TotalEndowmentFunds 2023-06-30 05668473 char:TotalEndowmentFunds 2022-06-30 05668473 char:TotalUnrestrictedFunds 2022-06-30 05668473 char:TotalUnrestrictedFunds 2022-07-01 2023-06-30 05668473 char:TotalUnrestrictedFunds 2021-07-01 2022-06-30 05668473 char:Activity1 char:TotalUnrestrictedFunds 2022-07-01 2023-06-30 05668473 char:Activity1 2022-07-01 2023-06-30 05668473 char:Activity1 2021-07-01 2022-06-30 05668473 char:Activity1 char:TotalUnrestrictedFunds 2021-07-01 2022-06-30 05668473 core:AfterOneYear 2023-06-30 05668473 core:AfterOneYear 2022-06-30 05668473 bus:FRS102 2022-07-01 2023-06-30 05668473 bus:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 05668473 bus:FullAccounts 2022-07-01 2023-06-30 05668473 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 05668473 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30
COMPANY REGISTRATION NUMBER: 05668473
CHARITY REGISTRATION NUMBER: 1112905
The Lee Smith Foundation Limited
Company Limited by Guarantee
Unaudited Financial Statements
30 June 2023
The Lee Smith Foundation Limited
Company Limited by Guarantee
Financial Statements
Year ended 30 June 2023
Page
Trustees' annual report (incorporating the director's report)
1
Statement of financial activities (including income and expenditure account)
4
Statement of financial position
5
Notes to the financial statements
6
The Lee Smith Foundation Limited
Company Limited by Guarantee
Trustees' Annual Report (Incorporating the Director's Report)
Year ended 30 June 2023
The trustees, who are also the directors for the purposes of company law, present their report and the unaudited financial statements of the charity for the year ended 30 June 2023 .
Reference and administrative details
Registered charity name
The Lee Smith Foundation Limited
Charity registration number
1112905
Company registration number
05668473
Principal office and registered
27 Old Gloucester Street
office
London
WC1N 3AX
The trustees
Mr Smith
Mr Bourne
Company secretary
S Bourne
Accountants
Davis Bonley
Chartered accountants
Northside House
Mount Pleasant
Barnet
Herts
EN4 9EE
Structure, governance and management
The trustees who served the company during the period were as follows:
Mr JA Smith
Mr S Bourne
Objectives and activities
The Lee Smith Foundation Limited is a charitable company limited by guarantee, incorporated on 6th January 2006 and registered as a charity. On 1st July 2006 the company took over the assets and liabilities of the Lee Smith Research Foundation, a charity registered with the Charity Commission under registration number 285028. Since that time it has taken over the activities of that organisation.
Objectives for the public benefit:-
-The supply, support and promotion of care and medical research for the benefit of sick and disabled persons -To cure, treat and prevent cancer and associated conditions and other debilitating diseases and disabilities. -The procurement and provision of, or assisting in the procurement and provision of, medical equipment, facilities or services for the benefit of sick and disabled persons in particular, but without prejudice to the generality of the foregoing, those suffering from cancer and associated conditions. To join with, collaborate with, or support other charitable bodies engaged in similar activities, provided that all useful results of such research are published.
In setting these objectives the Trustees confirm that they have had regards to the guidance contained in the Charity Commission's general guidance on public benefit. Trustees are appointed by the existing Trustees. The trustees named on page 1 served throughout the year. The directors of the company are also charity Trustees for the purposes of the charity law.
Achievements and performance
The foundation made donations of £700 (2022 - £1,000) in the year to 30th June 2023. It is the usual policy of the Trustees to make awards from the accumulated unrestricted funds only. Over the next year, the Trustees plan to aid and fund ongoing life-saving medical treatments and medical research projects.
Following the success of the Foundation's Gene Therapy project, a new foundation scientist is now working on a three year project with a natural placental stem cell treatment (organ and tissue repair) together with laser therapy for brain damage in babies and also prostate cancer. This treatment may also be used for leukemia and ovarian cancer. The Foundation is now ready to support new projects whilst continuing to aid additional worthwhile registered causes.
Whilst the charity has completed its current commitments, it is envisaged that further active fund raising to support new research projects will commence in 2023/24.
Financial review
The Statement of Financial Activities on page 4 shows the result of the period. After taking account of expenditure of charitable activities amounting to £700 (2022 - £1,000), there was an excess of expended resources over incoming resources of £1,653 (2022 - £2,139).
The Statement of Financial Position on page 5 shows the financial position of the Foundation as at 30 June 2023.
Net assets amounted to £36,475 (2022 - £38,128) which are represented by the accumulated balances on both the expendable endowment and unrestricted income funds. The net assets of expendable endowment fund and the unrestricted income fund are held in order to meet the ongoing overheads and administrative expenses, if any, and also to be applied towards the Foundation's charitable objectives.
The foundation has made commitments to fund cancer and organ/tissue repairs treatment for three years, with placental stem cells and laser therapy. During the year, the Foundation funded placental stem cells and laser therapy.
The foundation has also funded a variety of other medical projects for the benefit of patients needing treatment.
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
The trustees' annual report was approved on 14 August 2023 and signed on behalf of the board of trustees by:
Mr Smith
Trustee
The Lee Smith Foundation Limited
Company Limited by Guarantee
Statement of Financial Activities
(including income and expenditure account)
Year ended 30 June 2023
2023
2022
Unrestricted funds
Endowment funds
Total funds
Total funds
Note
£
£
£
£
Income and endowments
Donations and legacies
5
100
Investment income
6
163
163
22
----
----
----
----
Total income
163
163
122
----
----
----
----
Expenditure
Expenditure on raising funds:
Costs of raising donations and legacies
7
700
700
1,000
Expenditure on charitable activities
8,9
1,116
1,116
1,261
-------
----
-------
-------
Total expenditure
1,816
1,816
2,261
-------
----
-------
-------
-------
----
-------
-------
Net expenditure and net movement in funds
( 1,653)
( 1,653)
( 2,139)
-------
----
-------
-------
Reconciliation of funds
Total funds brought forward
37,128
1,000
38,128
40,267
--------
-------
--------
--------
Total funds carried forward
35,475
1,000
36,475
38,128
--------
-------
--------
--------
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities.
The Lee Smith Foundation Limited
Company Limited by Guarantee
Statement of Financial Position
30 June 2023
2023
2022
Note
£
£
Current assets
Cash at bank and in hand
37,578
39,231
--------
--------
Net current assets
37,578
39,231
--------
--------
Total assets less current liabilities
37,578
39,231
Creditors: amounts falling due after more than one year
11
1,103
1,103
--------
--------
Net assets
36,475
38,128
--------
--------
Funds of the charity
Endowment funds
1,000
1,000
Unrestricted funds
35,475
37,128
--------
--------
Total charity funds
12
36,475
38,128
--------
--------
For the year ending 30 June 2023 the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
These financial statements were approved by the board of trustees and authorised for issue on 14 August 2023 , and are signed on behalf of the board by:
Mr Smith
Trustee
The Lee Smith Foundation Limited
Company Limited by Guarantee
Notes to the Financial Statements
Year ended 30 June 2023
1. General information
The charity is a public benefit entity and a private company limited by guarantee, registered in England and Wales and a registered charity in England and Wales. The address of the registered office is 27 Old Gloucester Street, London, WC1N 3AX.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102)) and the Companies Act 2006.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure. The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
There are no material uncertainties about the charity's ability to continue.
Judgements and key sources of estimation uncertainty
There were no judgements (apart from those involving estimations) that management has made in the process of applying the entity's accounting policies and that have had the most significant effect on the amounts recognised in the financial statements.
Fund accounting
Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes. Designated funds are unrestricted funds earmarked by the trustees for particular future project or commitment. Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-classes: restricted income funds or endowment funds.
Incoming resources
All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income: - income from donations or grants is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably. - legacy income is recognised when receipt is probable and entitlement is established. - income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estimated resale value. Donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers. - income from contracts for the supply of services is recognised with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted.
Resources expended
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:
- expenditure on raising funds includes the costs of all fundraising activities, events, non-charitable trading activities, and the sale of donated goods.
- expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities.
- other expenditure includes all expenditure that is neither related to raising funds for the charity nor part of its expenditure on charitable activities.
All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.
Financial instruments
A financial asset or a financial liability is recognised only when the charity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs. Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted. Debt instruments are subsequently measured at amortised cost. Where investments in shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in income and expenditure. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in the statement of financial activities, with the exception of hedging instruments in a designated hedging relationship. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised under the appropriate heading in the statement of financial activities in which the initial gain was recognised. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Limited by guarantee
The Lee Smith Foundation Limited is a company limited by guarantee and accordingly does not have a share capital. Every member of the company undertakes to contribute such amount as may be required not exceeding £1 to the assets of the charitable company in the event of its being wound up while he or she is a member, or within one year after he or she ceases to be a member.
5. Donations and legacies
Unrestricted Funds
Total Funds 2023
Unrestricted Funds
Total Funds 2022
£
£
£
£
Donations
Donations type 1
100
100
----
----
----
----
6. Investment income
Unrestricted Funds
Total Funds 2023
Unrestricted Funds
Total Funds 2022
£
£
£
£
Bank interest receivable type 1
163
163
22
22
----
----
----
----
7. Costs of raising donations and legacies
Unrestricted Funds
Total Funds 2023
Unrestricted Funds
Total Funds 2022
£
£
£
£
Costs of raising donations and legacies - Donations
700
700
1,000
1,000
----
----
-------
-------
8. Expenditure on charitable activities by fund type
Unrestricted Funds
Total Funds 2023
Unrestricted Funds
Total Funds 2022
£
£
£
£
Support costs
1,116
1,116
1,261
1,261
-------
-------
-------
-------
9. Expenditure on charitable activities by activity type
Support costs
Total funds 2023
Total fund 2022
£
£
£
Governance costs
1,116
1,116
1,261
-------
-------
-------
10. Trustee remuneration and expenses
No remuneration or other benefits from employment with the charity or a related entity were received by the trustees.
11. Creditors: amounts falling due after more than one year
2023
2022
£
£
Accruals and deferred income
960
960
Director loan accounts
143
143
-------
-------
1,103
1,103
-------
-------
12. Analysis of charitable funds
Unrestricted funds
At 1 July 2022
Income
Expenditure
At 30 June 2023
£
£
£
£
General funds
37,128
163
(1,816)
35,475
--------
----
-------
--------
At 1 July 2021
Income
Expenditure
At 30 June 2022
£
£
£
£
General funds
39,267
122
(2,261)
37,128
--------
----
-------
--------
Endowment funds
At 1 July 2022
Income
Expenditure
At 30 June 2023
£
£
£
£
Expendable Endowment Fund 1 - desc in a/cs
1,000
1,000
-------
----
----
-------
At 1 July 2021
Income
Expenditure
At 30 June 2022
£
£
£
£
Expendable Endowment Fund 1 - desc in a/cs
1,000
1,000
-------
----
----
-------
13. Analysis of net assets between funds
Unrestricted Funds
Total Funds 2023
£
£
Current assets
37,578
37,578
Creditors less than 1 year
(1,103)
(1,103)
--------
--------
Net assets
36,475
36,475
--------
--------
Unrestricted Funds
Total Funds 2022
£
£
Current assets
39,231
39,231
Creditors less than 1 year
(1,103)
(1,103)
--------
--------
Net assets
38,128
38,128
--------
--------